The HIV field has two new approved prevention options waiting in the wings, the dapivirine vaginal ring (PrEP Ring) and injectable cabotegravir as PrEP (CAB for PrEP). In this podcast episode of Px Pulse, we dive into what lessons the field has learned, what’s still off-track, and the steps advocates, policy makers, drug makers and funders should each take right now to turn efficacious options into effective choices.